Tata group may launch Moderna Vaccine in India

New Delhi, 25/1: In a major development, Tata Group’s healthcare department has already started an initial discussion with Moderna Inc for a partnership to launch its Corona vaccines in India, according to the reports from Economic Times.

Tata Medical & Diagnostics may team up with India’s Council of Scientific and Industrial Research to carry out the clinical trials of Moderna Vaccines.

Unlike Pfizer’s vaccine, which must be kept at minus 70 degrees Celsius or below, Moderna’s can be stored at normal fridge temperatures, making it more suited for poorer countries such as India where cold chains are limited.

Comments are closed.